← FDA Drug Approvals (Drugs@FDA)

SYMFI LO

NDA · New Drug Application · Sponsor: MYLAN · Approved 2018-02-05

Drug application

FDA Application #

NDA208255

Application type

New Drug Application

Brand name

SYMFI LO

Generic name

Efavirenz

Active ingredients

EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

MYLAN

First approval

2018-02-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown